Clinical Trials Logo

Cardiovascular Disease clinical trials

View clinical trials related to Cardiovascular Disease.

Filter by:
  • Not yet recruiting  
  • Page 1 ·  Next »

NCT ID: NCT04726722 Not yet recruiting - Clinical trials for Cardiovascular Disease

Evaluation of a Personcentered Internet-based CBT Program for Stress, Anxiety and Depressive Symptoms in Patients With Cardiovascular Disease

Start date: February 2022
Phase: N/A
Study type: Interventional

To evaluate a nine-week adaptable and person-centred I-CBT program that can be directed towards stress, anxiety and depressive symptoms in persons with CVD.

NCT ID: NCT04623190 Not yet recruiting - Clinical trials for Cardiovascular Disease

Using Health Information Technology to Improve Health Behaviors and Promote Cardiovascular Health Among Adolescent and Young Adult Cancer Survivors

Start date: March 31, 2021
Phase: N/A
Study type: Interventional

Health information technology (HIT) has the potential to improve the quality, efficiency, consistency, and availability of cancer survivor care. PREVENT is a novel HIT tool designed by our team for adolescents (12-19 years). PREVENT aggregates and displays the American Heart Association's (AHA) Life Simple 7 cardiovascular health (CVH) risk factors and provides tailored, evidence-based, behavior change recommendations inclusive of community resources that are delivered to overweight/obese adolescents at the point-of-care to improve CVH. The investigators seek to expand this tool for patients beyond 19 years of age to increase this tool's reach to the entire adolescent and young adult (AYA) age range and then evaluate its effectiveness among AYA cancer survivors.

NCT ID: NCT04611932 Not yet recruiting - Clinical trials for Cardiovascular Disease

Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-333 Low Dose in Healthy Volunteers

Start date: November 11, 2020
Phase: Phase 1
Study type: Interventional

This study is a randomized, open-label, single dose, 3-period partial replicated crossover study to evaluate the pharmacokinetic profiles and safety of CKD-333 low dose in healthy volunteers under fasting conditions.

NCT ID: NCT04478097 Not yet recruiting - Clinical trials for Cardiovascular Disease

Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics in Healthy Volunteers

Start date: July 14, 2020
Phase: Phase 1
Study type: Interventional

This study is a randomized, open, single-dose, 3 period partial replicated crossover-design study to investigate the pharmacokinetic profiles and safety of CKD-333 in healthy volunteers.

NCT ID: NCT04444362 Not yet recruiting - Clinical trials for Cardiovascular Disease

Effects of IMT on Clinical Outcomes in Cardiac Surgery

Start date: July 1, 2020
Phase: N/A
Study type: Interventional

Individuals who underwent cardiac surgery may experience anesthesia, intracardiac operation, cardiopulmonary bypass and mechanical ventilation, which will result in a lot of injuries. Inspiratory Muscle Training (IMT) is a regimen of breathing exercises that aim to strengthen the respiratory muscles and make it easier for a person to breathe. The aim of this study was to evaluate the efficacy of preoperative IMT on e clinical outcomes in patients with cardiac surgery.

NCT ID: NCT04444349 Not yet recruiting - Clinical trials for Cardiovascular Disease

Effects of CoQ10 on Inflammatory Response in Cardiac Surgery

Start date: August 1, 2020
Phase: N/A
Study type: Interventional

Cardiovascular diseases are the leading causes of death and prescription drug use. Research on certain dietary supplements looks promising as a way to help reduce risk factors. Previous studies showed that CoQ10 levels were decreased in cardiovascular patients and worsening of mitochondrial dysfunction was observed. The overall objective of this study is to determine if supplementing with CoQ10 can reduce inflammatory risk factors in adults with cardiac surgery, independent of other dietary or physical activity changes.

NCT ID: NCT02898467 Not yet recruiting - Diabetes Clinical Trials

Atherothrombosis Markers in Diabetics

MADI
Start date: October 2016
Phase: N/A
Study type: Observational

Intraplaque hemorrhage is the driving force of atherothrombotic plaque vulnerability to rupture and associated clinical complications. Polymorphonuclear neutrophils (PMNs) represent about 70% of leukocytes and may constitute a source of proteases and oxidants that favour plaque rupture. Our objective is to evaluate PMN activation in atherosclerotic plaque of non-diabetic versus type 2 diabetic patients. For this purpose, investigators will quantify the presence of cell-free DNA, that reflect the formation of neutrophil extracellular traps (NETs) in carotid endarterectomy samples.

NCT ID: NCT02720809 Not yet recruiting - Clinical trials for Cardiovascular Disease

Health2016: Monitoring Chronic Disease and Risk Factors in the General Population

Start date: May 2016
Phase: N/A
Study type: Observational

Health2016 is a general population cross-sectional study aimed at completing af monitoring program for monitoring chronic disease and risk factors in the period 2006 to 2016. Similar studies have been performed in 2006, 2010, and 2013.

NCT ID: NCT02677467 Not yet recruiting - Clinical trials for Cardiovascular Disease

Correlation Between Epistaxis and Cardiovascular Disease

CBECD
Start date: March 2016
Phase: N/A
Study type: Observational [Patient Registry]

Investigators examine blood-pressure variance, several cardiovascular risk factors of patient with epistaxis. As a result of collected data, investigators look into correlation between epistaxis and hypertensive cardiovascular disorder.

NCT ID: NCT02578355 Not yet recruiting - Clinical trials for Coronary Artery Disease

National Plaque Registry and Database

OPeRA
Start date: September 2016
Phase: N/A
Study type: Observational [Patient Registry]

The ultimate goal of this project is to develop a risk score to identify patients with vulnerable coronary atherosclerotic plaques, who are prone to suffer acute coronary syndrome. Early identification of vulnerable plaques may have an enormous impact on public health through primary and secondary prevention of acute myocardial infarction. Investigators hypothesize that a risk score that incorporates non-invasive coronary CT imaging (calcium score and/or coronary CTA) in combination with clinical characteristics (classical risk prediction models) will improve the identification of patients who are at highest risk to suffer myocardial infarction or sudden cardiac death. The overall goal of the OPeRA project is to develop, implement and validate a novel risk assessment tool based on image markers and clinical characteristics to identify patients who are at increased risk to suffer myocardial infarction or sudden cardiac death.